Symrise AG, Holzminden/Germany has signed a minority investment agreement with Bonumose. The early-stage food ingredient manufacturer specializes in the affordable production of “good-for-you” rare monosaccharides (alternatives to sucrose) such as tagatose and allulose. With this strategic transaction, Symrise will accelerate growth in its sugar reduction initiatives. The area represents a high-priority focus for the North America region within the Taste, Nutrition & Health segment.
Ed Rogers, Bonumose Chief Executive Officer and Co-Founder said:
“We feel enthusiastic about the future and the growth that the investment and partnership with Symrise enables. Now, we are coupling our expertise in tagatose and other naturally-occurring sugar alternatives with the extensive Symrise flavor proficiency and expansive portfolio across multiple platforms in both human food and animal nutrition. This creates the opportunity to offer unique value to customers. The strength of Symrise as an augmented flavor house paired with Bonumose’s patented enzymatic technology will enable cutting edge solutions to sugar reduction.”
About Bonumose:
The growth-stage startup food ingredient and enzyme innovation company Bonumose is based near Charlottesville, Virginia. Bonumose gets support from strategic investors and “food for health”-focused institutional investors, and an expanding network of global collaboration partners across the value chain. Bonumose developed and patented the methods for continuous production of high-purity tagatose, allulose and other good-for-you ingredients from abundant, plant-based starch. Beyond sugar alternatives, Bonumose also offers solutions for dietary supplements, crop protection, animal nutrition, and other globally-significant industries. Due to the public health significance of Bonumose’s innovations, the World Economic Forum named Bonumose as a “Technology Pioneer.” Bonumose operates with a philosophy of Business as a Moral Imperative.
Source and picture: Symrise
